Funds trio key shareholders in Open Orphan merger firm

Funds trio key shareholders in Open Orphan merger firm
Open Orphan boss Cathal Friel

A trio of London funds have emerged as major shareholders in Venn Life Sciences as part of its merger with Open Orphan.

The company announced last week that it has raised £4.5 million (€5 million) from investors to fund the reverse takeover of Dublin-based Open Orphan.

According to regulatory filings on Friday, Miton Asset Management and Crux Asset Management will each own 3.5 per cent of Open Orphan after the fundraising is complete. Livingbridge, a venture capital...

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post